nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—CLK1—female reproductive system—rectum cancer	0.000812	0.00154	CbGeAlD
Sunitinib—CLK4—lymph node—rectum cancer	0.000811	0.00154	CbGeAlD
Sunitinib—IRAK1—mammalian vulva—rectum cancer	0.000811	0.00154	CbGeAlD
Sunitinib—FGFR2—renal system—rectum cancer	0.000804	0.00153	CbGeAlD
Sunitinib—FLT1—epithelium—rectum cancer	0.000803	0.00153	CbGeAlD
Sunitinib—SBK1—lymph node—rectum cancer	0.000802	0.00152	CbGeAlD
Sunitinib—ITK—lymph node—rectum cancer	0.000802	0.00152	CbGeAlD
Sunitinib—MAP4K5—smooth muscle tissue—rectum cancer	0.0008	0.00152	CbGeAlD
Sunitinib—JAK2—renal system—rectum cancer	0.000799	0.00152	CbGeAlD
Sunitinib—BMP2K—female reproductive system—rectum cancer	0.000797	0.00151	CbGeAlD
Sunitinib—CAMK2G—female reproductive system—rectum cancer	0.000797	0.00151	CbGeAlD
Sunitinib—SLK—urethra—rectum cancer	0.000796	0.00151	CbGeAlD
Sunitinib—RPS6KB1—mammalian vulva—rectum cancer	0.000796	0.00151	CbGeAlD
Sunitinib—BLK—lymph node—rectum cancer	0.000792	0.00151	CbGeAlD
Sunitinib—FGR—mammalian vulva—rectum cancer	0.000791	0.0015	CbGeAlD
Sunitinib—MERTK—vagina—rectum cancer	0.000789	0.0015	CbGeAlD
Sunitinib—LRRK2—female reproductive system—rectum cancer	0.000789	0.0015	CbGeAlD
Sunitinib—FYN—renal system—rectum cancer	0.000788	0.0015	CbGeAlD
Sunitinib—AXL—mammalian vulva—rectum cancer	0.000788	0.0015	CbGeAlD
Sunitinib—JAK2—urethra—rectum cancer	0.000785	0.00149	CbGeAlD
Sunitinib—PHKG1—lymph node—rectum cancer	0.000784	0.00149	CbGeAlD
Sunitinib—DAPK1—lymph node—rectum cancer	0.000784	0.00149	CbGeAlD
Sunitinib—KDR—seminal vesicle—rectum cancer	0.000781	0.00148	CbGeAlD
Sunitinib—MAP2K5—seminal vesicle—rectum cancer	0.000781	0.00148	CbGeAlD
Sunitinib—PRKAA1—female reproductive system—rectum cancer	0.000778	0.00148	CbGeAlD
Sunitinib—MAP4K4—vagina—rectum cancer	0.000775	0.00147	CbGeAlD
Sunitinib—FYN—urethra—rectum cancer	0.000774	0.00147	CbGeAlD
Sunitinib—FLT1—smooth muscle tissue—rectum cancer	0.000774	0.00147	CbGeAlD
Sunitinib—NUAK2—vagina—rectum cancer	0.000769	0.00146	CbGeAlD
Sunitinib—PTK2B—female reproductive system—rectum cancer	0.000769	0.00146	CbGeAlD
Sunitinib—FLT4—female reproductive system—rectum cancer	0.000767	0.00146	CbGeAlD
Sunitinib—MAP3K12—vagina—rectum cancer	0.000764	0.00145	CbGeAlD
Sunitinib—CSF1R—seminal vesicle—rectum cancer	0.000763	0.00145	CbGeAlD
Sunitinib—STK11—lymph node—rectum cancer	0.000759	0.00144	CbGeAlD
Sunitinib—BRD4—lymph node—rectum cancer	0.000759	0.00144	CbGeAlD
Sunitinib—SLK—mammalian vulva—rectum cancer	0.000758	0.00144	CbGeAlD
Sunitinib—CSNK1E—female reproductive system—rectum cancer	0.000757	0.00144	CbGeAlD
Sunitinib—MAP3K3—urethra—rectum cancer	0.000757	0.00144	CbGeAlD
Sunitinib—MAP4K5—urethra—rectum cancer	0.000757	0.00144	CbGeAlD
Sunitinib—RPS6KA3—vagina—rectum cancer	0.000753	0.00143	CbGeAlD
Sunitinib—RPS6KA1—lymph node—rectum cancer	0.000751	0.00143	CbGeAlD
Sunitinib—RIOK1—lymph node—rectum cancer	0.000751	0.00143	CbGeAlD
Sunitinib—JAK2—mammalian vulva—rectum cancer	0.000747	0.00142	CbGeAlD
Sunitinib—FLT1—renal system—rectum cancer	0.000745	0.00141	CbGeAlD
Sunitinib—YES1—smooth muscle tissue—rectum cancer	0.000739	0.0014	CbGeAlD
Sunitinib—CSNK1A1—vagina—rectum cancer	0.000739	0.0014	CbGeAlD
Sunitinib—FYN—mammalian vulva—rectum cancer	0.000737	0.0014	CbGeAlD
Sunitinib—MARK2—lymph node—rectum cancer	0.000737	0.0014	CbGeAlD
Sunitinib—TNIK—lymph node—rectum cancer	0.000737	0.0014	CbGeAlD
Sunitinib—CLK1—vagina—rectum cancer	0.000734	0.00139	CbGeAlD
Sunitinib—FLT1—urethra—rectum cancer	0.000732	0.00139	CbGeAlD
Sunitinib—SGK3—lymph node—rectum cancer	0.00073	0.00139	CbGeAlD
Sunitinib—MAP2K2—female reproductive system—rectum cancer	0.000729	0.00138	CbGeAlD
Sunitinib—ULK3—female reproductive system—rectum cancer	0.000729	0.00138	CbGeAlD
Sunitinib—PDGFRA—smooth muscle tissue—rectum cancer	0.000725	0.00138	CbGeAlD
Sunitinib—MAP3K2—female reproductive system—rectum cancer	0.000723	0.00137	CbGeAlD
Sunitinib—EPHB6—urethra—rectum cancer	0.000723	0.00137	CbGeAlD
Sunitinib—ICK—lymph node—rectum cancer	0.000723	0.00137	CbGeAlD
Sunitinib—MAP3K3—mammalian vulva—rectum cancer	0.00072	0.00137	CbGeAlD
Sunitinib—MAP4K5—mammalian vulva—rectum cancer	0.00072	0.00137	CbGeAlD
Sunitinib—CAMK2G—vagina—rectum cancer	0.00072	0.00137	CbGeAlD
Sunitinib—BMP2K—vagina—rectum cancer	0.00072	0.00137	CbGeAlD
Sunitinib—LRRK2—vagina—rectum cancer	0.000714	0.00136	CbGeAlD
Sunitinib—YES1—renal system—rectum cancer	0.000711	0.00135	CbGeAlD
Sunitinib—TBK1—female reproductive system—rectum cancer	0.000708	0.00135	CbGeAlD
Sunitinib—STK10—renal system—rectum cancer	0.000705	0.00134	CbGeAlD
Sunitinib—TYK2—female reproductive system—rectum cancer	0.000704	0.00134	CbGeAlD
Sunitinib—TAOK3—renal system—rectum cancer	0.000702	0.00133	CbGeAlD
Sunitinib—YES1—urethra—rectum cancer	0.000699	0.00133	CbGeAlD
Sunitinib—CHEK2—lymph node—rectum cancer	0.000698	0.00133	CbGeAlD
Sunitinib—NUAK1—lymph node—rectum cancer	0.000698	0.00133	CbGeAlD
Sunitinib—PDGFRA—renal system—rectum cancer	0.000698	0.00133	CbGeAlD
Sunitinib—FLT1—mammalian vulva—rectum cancer	0.000697	0.00132	CbGeAlD
Sunitinib—PTK2B—vagina—rectum cancer	0.000696	0.00132	CbGeAlD
Sunitinib—IRAK1—female reproductive system—rectum cancer	0.000694	0.00132	CbGeAlD
Sunitinib—INSR—lymph node—rectum cancer	0.000693	0.00132	CbGeAlD
Sunitinib—SNRK—lymph node—rectum cancer	0.000693	0.00132	CbGeAlD
Sunitinib—OXSR1—lymph node—rectum cancer	0.000693	0.00132	CbGeAlD
Sunitinib—KIT—seminal vesicle—rectum cancer	0.000692	0.00132	CbGeAlD
Sunitinib—TAOK3—urethra—rectum cancer	0.00069	0.00131	CbGeAlD
Sunitinib—EPHB6—mammalian vulva—rectum cancer	0.000689	0.00131	CbGeAlD
Sunitinib—CSNK1E—vagina—rectum cancer	0.000685	0.0013	CbGeAlD
Sunitinib—FGFR1—vagina—rectum cancer	0.000685	0.0013	CbGeAlD
Sunitinib—STK38—lymph node—rectum cancer	0.000682	0.00129	CbGeAlD
Sunitinib—RPS6KA2—lymph node—rectum cancer	0.000682	0.00129	CbGeAlD
Sunitinib—RPS6KB1—female reproductive system—rectum cancer	0.000681	0.00129	CbGeAlD
Sunitinib—KDR—epithelium—rectum cancer	0.000679	0.00129	CbGeAlD
Sunitinib—FGR—female reproductive system—rectum cancer	0.000677	0.00129	CbGeAlD
Sunitinib—AURKC—lymph node—rectum cancer	0.000676	0.00128	CbGeAlD
Sunitinib—PDGFRB—seminal vesicle—rectum cancer	0.000676	0.00128	CbGeAlD
Sunitinib—AXL—female reproductive system—rectum cancer	0.000675	0.00128	CbGeAlD
Sunitinib—IRAK4—vagina—rectum cancer	0.000674	0.00128	CbGeAlD
Sunitinib—PKN1—lymph node—rectum cancer	0.000671	0.00128	CbGeAlD
Sunitinib—CSNK1G2—lymph node—rectum cancer	0.000671	0.00128	CbGeAlD
Sunitinib—YES1—mammalian vulva—rectum cancer	0.000665	0.00126	CbGeAlD
Sunitinib—PRPF4—lymph node—rectum cancer	0.000661	0.00126	CbGeAlD
Sunitinib—STK10—mammalian vulva—rectum cancer	0.000659	0.00125	CbGeAlD
Sunitinib—ULK3—vagina—rectum cancer	0.000659	0.00125	CbGeAlD
Sunitinib—TAOK3—mammalian vulva—rectum cancer	0.000657	0.00125	CbGeAlD
Sunitinib—KDR—smooth muscle tissue—rectum cancer	0.000654	0.00124	CbGeAlD
Sunitinib—PRPF4B—lymph node—rectum cancer	0.000652	0.00124	CbGeAlD
Sunitinib—MAP3K7—vagina—rectum cancer	0.000648	0.00123	CbGeAlD
Sunitinib—FGFR2—female reproductive system—rectum cancer	0.000644	0.00122	CbGeAlD
Sunitinib—STK39—lymph node—rectum cancer	0.000643	0.00122	CbGeAlD
Sunitinib—TBK1—vagina—rectum cancer	0.000641	0.00122	CbGeAlD
Sunitinib—JAK2—female reproductive system—rectum cancer	0.00064	0.00122	CbGeAlD
Sunitinib—CSF1R—smooth muscle tissue—rectum cancer	0.000638	0.00121	CbGeAlD
Sunitinib—TYK2—vagina—rectum cancer	0.000636	0.00121	CbGeAlD
Sunitinib—CSNK2A1—lymph node—rectum cancer	0.000635	0.00121	CbGeAlD
Sunitinib—FYN—female reproductive system—rectum cancer	0.000631	0.0012	CbGeAlD
Sunitinib—KDR—renal system—rectum cancer	0.00063	0.0012	CbGeAlD
Sunitinib—MYLK—lymph node—rectum cancer	0.000626	0.00119	CbGeAlD
Sunitinib—PLK4—lymph node—rectum cancer	0.000619	0.00118	CbGeAlD
Sunitinib—MAP2K5—urethra—rectum cancer	0.000618	0.00117	CbGeAlD
Sunitinib—KDR—urethra—rectum cancer	0.000618	0.00117	CbGeAlD
Sunitinib—MAP4K5—female reproductive system—rectum cancer	0.000617	0.00117	CbGeAlD
Sunitinib—MAP3K3—female reproductive system—rectum cancer	0.000617	0.00117	CbGeAlD
Sunitinib—RPS6KB1—vagina—rectum cancer	0.000616	0.00117	CbGeAlD
Sunitinib—STK4—lymph node—rectum cancer	0.000615	0.00117	CbGeAlD
Sunitinib—FGR—vagina—rectum cancer	0.000613	0.00116	CbGeAlD
Sunitinib—AXL—vagina—rectum cancer	0.00061	0.00116	CbGeAlD
Sunitinib—PHKG2—lymph node—rectum cancer	0.000604	0.00115	CbGeAlD
Sunitinib—CSF1R—urethra—rectum cancer	0.000604	0.00115	CbGeAlD
Sunitinib—KIT—epithelium—rectum cancer	0.000602	0.00114	CbGeAlD
Sunitinib—STK24—lymph node—rectum cancer	0.000601	0.00114	CbGeAlD
Sunitinib—FLT1—female reproductive system—rectum cancer	0.000597	0.00113	CbGeAlD
Sunitinib—DAPK2—lymph node—rectum cancer	0.000594	0.00113	CbGeAlD
Sunitinib—KDR—mammalian vulva—rectum cancer	0.000589	0.00112	CbGeAlD
Sunitinib—MAP2K5—mammalian vulva—rectum cancer	0.000589	0.00112	CbGeAlD
Sunitinib—PDGFRB—epithelium—rectum cancer	0.000588	0.00112	CbGeAlD
Sunitinib—SLK—vagina—rectum cancer	0.000587	0.00112	CbGeAlD
Sunitinib—STK16—lymph node—rectum cancer	0.000584	0.00111	CbGeAlD
Sunitinib—HIPK2—lymph node—rectum cancer	0.000581	0.0011	CbGeAlD
Sunitinib—HIPK3—lymph node—rectum cancer	0.000581	0.0011	CbGeAlD
Sunitinib—ALK—lymph node—rectum cancer	0.000581	0.0011	CbGeAlD
Sunitinib—KIT—smooth muscle tissue—rectum cancer	0.00058	0.0011	CbGeAlD
Sunitinib—JAK2—vagina—rectum cancer	0.000579	0.0011	CbGeAlD
Sunitinib—TNK1—lymph node—rectum cancer	0.000575	0.00109	CbGeAlD
Sunitinib—RIOK2—lymph node—rectum cancer	0.000575	0.00109	CbGeAlD
Sunitinib—CSF1R—mammalian vulva—rectum cancer	0.000575	0.00109	CbGeAlD
Sunitinib—FYN—vagina—rectum cancer	0.000571	0.00108	CbGeAlD
Sunitinib—YES1—female reproductive system—rectum cancer	0.00057	0.00108	CbGeAlD
Sunitinib—MAP4K1—lymph node—rectum cancer	0.000569	0.00108	CbGeAlD
Sunitinib—PDGFRB—smooth muscle tissue—rectum cancer	0.000566	0.00108	CbGeAlD
Sunitinib—STK10—female reproductive system—rectum cancer	0.000565	0.00107	CbGeAlD
Sunitinib—TAOK3—female reproductive system—rectum cancer	0.000563	0.00107	CbGeAlD
Sunitinib—PDGFRA—female reproductive system—rectum cancer	0.000559	0.00106	CbGeAlD
Sunitinib—DAPK3—lymph node—rectum cancer	0.000558	0.00106	CbGeAlD
Sunitinib—MAP4K5—vagina—rectum cancer	0.000558	0.00106	CbGeAlD
Sunitinib—MAP3K3—vagina—rectum cancer	0.000558	0.00106	CbGeAlD
Sunitinib—KIT—renal system—rectum cancer	0.000558	0.00106	CbGeAlD
Sunitinib—CLK2—lymph node—rectum cancer	0.000553	0.00105	CbGeAlD
Sunitinib—MAP4K2—lymph node—rectum cancer	0.000551	0.00105	CbGeAlD
Sunitinib—KIT—urethra—rectum cancer	0.000548	0.00104	CbGeAlD
Sunitinib—PDGFRB—renal system—rectum cancer	0.000545	0.00104	CbGeAlD
Sunitinib—STK3—lymph node—rectum cancer	0.000543	0.00103	CbGeAlD
Sunitinib—FLT1—vagina—rectum cancer	0.000539	0.00102	CbGeAlD
Sunitinib—PDGFRB—urethra—rectum cancer	0.000535	0.00102	CbGeAlD
Sunitinib—EPHB6—vagina—rectum cancer	0.000533	0.00101	CbGeAlD
Sunitinib—DYRK1A—lymph node—rectum cancer	0.000523	0.000993	CbGeAlD
Sunitinib—KIT—mammalian vulva—rectum cancer	0.000522	0.000991	CbGeAlD
Sunitinib—YES1—vagina—rectum cancer	0.000515	0.000979	CbGeAlD
Sunitinib—STK10—vagina—rectum cancer	0.000511	0.00097	CbGeAlD
Sunitinib—MERTK—lymph node—rectum cancer	0.000511	0.00097	CbGeAlD
Sunitinib—PDGFRB—mammalian vulva—rectum cancer	0.00051	0.000968	CbGeAlD
Sunitinib—TAOK3—vagina—rectum cancer	0.000509	0.000966	CbGeAlD
Sunitinib—PDGFRA—vagina—rectum cancer	0.000506	0.00096	CbGeAlD
Sunitinib—KDR—female reproductive system—rectum cancer	0.000504	0.000958	CbGeAlD
Sunitinib—MAP2K5—female reproductive system—rectum cancer	0.000504	0.000958	CbGeAlD
Sunitinib—MAP4K4—lymph node—rectum cancer	0.000501	0.000952	CbGeAlD
Sunitinib—NUAK2—lymph node—rectum cancer	0.000498	0.000945	CbGeAlD
Sunitinib—FLT3—lymph node—rectum cancer	0.000494	0.000939	CbGeAlD
Sunitinib—MAP3K12—lymph node—rectum cancer	0.000494	0.000939	CbGeAlD
Sunitinib—CSF1R—female reproductive system—rectum cancer	0.000492	0.000935	CbGeAlD
Sunitinib—RPS6KA3—lymph node—rectum cancer	0.000487	0.000926	CbGeAlD
Sunitinib—MAP2K1—lymph node—rectum cancer	0.000484	0.00092	CbGeAlD
Sunitinib—CSNK1A1—lymph node—rectum cancer	0.000478	0.000908	CbGeAlD
Sunitinib—CLK1—lymph node—rectum cancer	0.000475	0.000902	CbGeAlD
Sunitinib—CAMK2G—lymph node—rectum cancer	0.000466	0.000885	CbGeAlD
Sunitinib—BMP2K—lymph node—rectum cancer	0.000466	0.000885	CbGeAlD
Sunitinib—LRRK2—lymph node—rectum cancer	0.000462	0.000877	CbGeAlD
Sunitinib—KDR—vagina—rectum cancer	0.000456	0.000866	CbGeAlD
Sunitinib—MAP2K5—vagina—rectum cancer	0.000456	0.000866	CbGeAlD
Sunitinib—PRKAA1—lymph node—rectum cancer	0.000455	0.000865	CbGeAlD
Sunitinib—PTK2B—lymph node—rectum cancer	0.00045	0.000855	CbGeAlD
Sunitinib—FLT4—lymph node—rectum cancer	0.000449	0.000852	CbGeAlD
Sunitinib—KIT—female reproductive system—rectum cancer	0.000447	0.000849	CbGeAlD
Sunitinib—CSF1R—vagina—rectum cancer	0.000445	0.000845	CbGeAlD
Sunitinib—CSNK1E—lymph node—rectum cancer	0.000443	0.000841	CbGeAlD
Sunitinib—FGFR1—lymph node—rectum cancer	0.000443	0.000841	CbGeAlD
Sunitinib—PDGFRB—female reproductive system—rectum cancer	0.000436	0.000829	CbGeAlD
Sunitinib—IRAK4—lymph node—rectum cancer	0.000436	0.000828	CbGeAlD
Sunitinib—ABCC4—renal system—rectum cancer	0.000434	0.000824	CbGeAlD
Sunitinib—KCNH2—seminal vesicle—rectum cancer	0.000427	0.000812	CbGeAlD
Sunitinib—ULK3—lymph node—rectum cancer	0.000426	0.00081	CbGeAlD
Sunitinib—MAP2K2—lymph node—rectum cancer	0.000426	0.00081	CbGeAlD
Sunitinib—MAP3K2—lymph node—rectum cancer	0.000423	0.000804	CbGeAlD
Sunitinib—ABCC2—renal system—rectum cancer	0.00042	0.000798	CbGeAlD
Sunitinib—MAP3K7—lymph node—rectum cancer	0.000419	0.000796	CbGeAlD
Sunitinib—TBK1—lymph node—rectum cancer	0.000414	0.000787	CbGeAlD
Sunitinib—TYK2—lymph node—rectum cancer	0.000412	0.000782	CbGeAlD
Sunitinib—IRAK1—lymph node—rectum cancer	0.000406	0.000772	CbGeAlD
Sunitinib—KIT—vagina—rectum cancer	0.000404	0.000768	CbGeAlD
Sunitinib—RPS6KB1—lymph node—rectum cancer	0.000399	0.000757	CbGeAlD
Sunitinib—FGR—lymph node—rectum cancer	0.000396	0.000753	CbGeAlD
Sunitinib—RET—lymph node—rectum cancer	0.000396	0.000753	CbGeAlD
Sunitinib—PDGFRB—vagina—rectum cancer	0.000395	0.00075	CbGeAlD
Sunitinib—AXL—lymph node—rectum cancer	0.000395	0.00075	CbGeAlD
Sunitinib—ABCG2—seminal vesicle—rectum cancer	0.00038	0.000722	CbGeAlD
Sunitinib—SLK—lymph node—rectum cancer	0.00038	0.000722	CbGeAlD
Sunitinib—JAK2—lymph node—rectum cancer	0.000374	0.000711	CbGeAlD
Sunitinib—FYN—lymph node—rectum cancer	0.000369	0.000702	CbGeAlD
Sunitinib—MAP3K3—lymph node—rectum cancer	0.000361	0.000686	CbGeAlD
Sunitinib—MAP4K5—lymph node—rectum cancer	0.000361	0.000686	CbGeAlD
Sunitinib—FLT1—lymph node—rectum cancer	0.000349	0.000663	CbGeAlD
Sunitinib—ABCC4—female reproductive system—rectum cancer	0.000348	0.00066	CbGeAlD
Sunitinib—EPHB6—lymph node—rectum cancer	0.000345	0.000655	CbGeAlD
Sunitinib—KCNH2—renal system—rectum cancer	0.000344	0.000654	CbGeAlD
Sunitinib—KCNH2—urethra—rectum cancer	0.000338	0.000642	CbGeAlD
Sunitinib—ABCC2—female reproductive system—rectum cancer	0.000336	0.000639	CbGeAlD
Sunitinib—YES1—lymph node—rectum cancer	0.000333	0.000633	CbGeAlD
Sunitinib—STK10—lymph node—rectum cancer	0.00033	0.000627	CbGeAlD
Sunitinib—TAOK3—lymph node—rectum cancer	0.000329	0.000625	CbGeAlD
Sunitinib—PDGFRA—lymph node—rectum cancer	0.000327	0.000621	CbGeAlD
Sunitinib—ABCG2—urethra—rectum cancer	0.000301	0.000572	CbGeAlD
Sunitinib—KDR—lymph node—rectum cancer	0.000295	0.00056	CbGeAlD
Sunitinib—MAP2K5—lymph node—rectum cancer	0.000295	0.00056	CbGeAlD
Sunitinib—CSF1R—lymph node—rectum cancer	0.000288	0.000547	CbGeAlD
Sunitinib—ABCG2—mammalian vulva—rectum cancer	0.000286	0.000544	CbGeAlD
Sunitinib—CYP3A5—renal system—rectum cancer	0.000284	0.00054	CbGeAlD
Sunitinib—KCNH2—female reproductive system—rectum cancer	0.000276	0.000524	CbGeAlD
Sunitinib—KIT—lymph node—rectum cancer	0.000261	0.000497	CbGeAlD
Sunitinib—PDGFRB—lymph node—rectum cancer	0.000255	0.000485	CbGeAlD
Sunitinib—KCNH2—vagina—rectum cancer	0.000249	0.000474	CbGeAlD
Sunitinib—ABCG2—vagina—rectum cancer	0.000222	0.000421	CbGeAlD
Sunitinib—CYP3A4—renal system—rectum cancer	0.000213	0.000405	CbGeAlD
Sunitinib—CYP3A5—vagina—rectum cancer	0.000206	0.000391	CbGeAlD
Sunitinib—ABCC4—lymph node—rectum cancer	0.000203	0.000386	CbGeAlD
Sunitinib—ABCC2—lymph node—rectum cancer	0.000197	0.000374	CbGeAlD
Sunitinib—ABCB1—seminal vesicle—rectum cancer	0.000187	0.000356	CbGeAlD
Sunitinib—CYP3A4—female reproductive system—rectum cancer	0.000171	0.000325	CbGeAlD
Sunitinib—ABCB1—epithelium—rectum cancer	0.000163	0.000309	CbGeAlD
Sunitinib—KCNH2—lymph node—rectum cancer	0.000161	0.000306	CbGeAlD
Sunitinib—ABCB1—renal system—rectum cancer	0.000151	0.000287	CbGeAlD
Sunitinib—ABCB1—urethra—rectum cancer	0.000148	0.000282	CbGeAlD
Sunitinib—ABCG2—lymph node—rectum cancer	0.000144	0.000273	CbGeAlD
Sunitinib—ABCB1—mammalian vulva—rectum cancer	0.000141	0.000268	CbGeAlD
Sunitinib—ABCB1—female reproductive system—rectum cancer	0.000121	0.00023	CbGeAlD
Sunitinib—ABCB1—vagina—rectum cancer	0.000109	0.000208	CbGeAlD
Sunitinib—ABCB1—lymph node—rectum cancer	7.08e-05	0.000134	CbGeAlD
Sunitinib—PRKAA2—Signaling Pathways—KRAS—rectum cancer	2.66e-05	5.61e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—HRAS—rectum cancer	2.66e-05	5.61e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—KRAS—rectum cancer	2.65e-05	5.6e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—HRAS—rectum cancer	2.65e-05	5.59e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—TP53—rectum cancer	2.64e-05	5.58e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—TP53—rectum cancer	2.64e-05	5.58e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	2.64e-05	5.57e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—KRAS—rectum cancer	2.64e-05	5.57e-05	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—HRAS—rectum cancer	2.63e-05	5.55e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—NRAS—rectum cancer	2.6e-05	5.48e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—HRAS—rectum cancer	2.59e-05	5.47e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—KRAS—rectum cancer	2.59e-05	5.47e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—HRAS—rectum cancer	2.59e-05	5.46e-05	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—HRAS—rectum cancer	2.58e-05	5.45e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—HRAS—rectum cancer	2.58e-05	5.45e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—NRAS—rectum cancer	2.58e-05	5.44e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—HRAS—rectum cancer	2.56e-05	5.41e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—TP53—rectum cancer	2.56e-05	5.41e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—HRAS—rectum cancer	2.55e-05	5.39e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—HRAS—rectum cancer	2.53e-05	5.33e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—HRAS—rectum cancer	2.53e-05	5.33e-05	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—HRAS—rectum cancer	2.52e-05	5.33e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—KRAS—rectum cancer	2.52e-05	5.33e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—KRAS—rectum cancer	2.51e-05	5.31e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—KRAS—rectum cancer	2.5e-05	5.27e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—KRAS—rectum cancer	2.49e-05	5.25e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—KRAS—rectum cancer	2.49e-05	5.25e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—KRAS—rectum cancer	2.48e-05	5.24e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—HRAS—rectum cancer	2.48e-05	5.23e-05	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—HRAS—rectum cancer	2.48e-05	5.23e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TP53—rectum cancer	2.46e-05	5.2e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—KRAS—rectum cancer	2.46e-05	5.2e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—KRAS—rectum cancer	2.45e-05	5.18e-05	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—HRAS—rectum cancer	2.45e-05	5.17e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—HRAS—rectum cancer	2.45e-05	5.17e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—HRAS—rectum cancer	2.44e-05	5.16e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—TYMS—rectum cancer	2.43e-05	5.13e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—TYMS—rectum cancer	2.41e-05	5.09e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—HRAS—rectum cancer	2.41e-05	5.08e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—HRAS—rectum cancer	2.4e-05	5.07e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—KRAS—rectum cancer	2.4e-05	5.06e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—HRAS—rectum cancer	2.39e-05	5.05e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—KRAS—rectum cancer	2.37e-05	5.01e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—KRAS—rectum cancer	2.37e-05	5e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TP53—rectum cancer	2.36e-05	4.99e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—HRAS—rectum cancer	2.36e-05	4.98e-05	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—HRAS—rectum cancer	2.35e-05	4.97e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—HRAS—rectum cancer	2.35e-05	4.95e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	2.34e-05	4.95e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TP53—rectum cancer	2.34e-05	4.95e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—HRAS—rectum cancer	2.34e-05	4.94e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—HRAS—rectum cancer	2.32e-05	4.91e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—NRAS—rectum cancer	2.32e-05	4.9e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—NRAS—rectum cancer	2.3e-05	4.86e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—HRAS—rectum cancer	2.28e-05	4.82e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—HRAS—rectum cancer	2.26e-05	4.77e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—HRAS—rectum cancer	2.26e-05	4.77e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—HRAS—rectum cancer	2.26e-05	4.76e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—HRAS—rectum cancer	2.24e-05	4.73e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—KRAS—rectum cancer	2.23e-05	4.72e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TP53—rectum cancer	2.23e-05	4.72e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—NRAS—rectum cancer	2.22e-05	4.7e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—KRAS—rectum cancer	2.22e-05	4.68e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TP53—rectum cancer	2.21e-05	4.67e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—HRAS—rectum cancer	2.2e-05	4.65e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—NRAS—rectum cancer	2.18e-05	4.61e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—HRAS—rectum cancer	2.14e-05	4.53e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—HRAS—rectum cancer	2.14e-05	4.51e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—HRAS—rectum cancer	2.12e-05	4.48e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—NRAS—rectum cancer	2.12e-05	4.47e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—HRAS—rectum cancer	2.11e-05	4.46e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—HRAS—rectum cancer	2.11e-05	4.46e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—HRAS—rectum cancer	2.11e-05	4.46e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TP53—rectum cancer	2.11e-05	4.45e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—HRAS—rectum cancer	2.09e-05	4.42e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—NRAS—rectum cancer	2.09e-05	4.42e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—NRAS—rectum cancer	2.09e-05	4.41e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—HRAS—rectum cancer	2.09e-05	4.4e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—NRAS—rectum cancer	2.07e-05	4.37e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—NRAS—rectum cancer	2.05e-05	4.34e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—NRAS—rectum cancer	2.05e-05	4.34e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HRAS—rectum cancer	2.04e-05	4.3e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—HRAS—rectum cancer	2.02e-05	4.26e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—HRAS—rectum cancer	2.01e-05	4.25e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—KRAS—rectum cancer	2e-05	4.21e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—rectum cancer	1.99e-05	4.19e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—KRAS—rectum cancer	1.98e-05	4.18e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—rectum cancer	1.97e-05	4.16e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—NRAS—rectum cancer	1.97e-05	4.15e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—NRAS—rectum cancer	1.96e-05	4.13e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—NRAS—rectum cancer	1.95e-05	4.12e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—NRAS—rectum cancer	1.95e-05	4.11e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—NRAS—rectum cancer	1.93e-05	4.08e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—KRAS—rectum cancer	1.91e-05	4.04e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—HRAS—rectum cancer	1.9e-05	4.01e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—NRAS—rectum cancer	1.9e-05	4.01e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—NRAS—rectum cancer	1.89e-05	4e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—HRAS—rectum cancer	1.88e-05	3.98e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—KRAS—rectum cancer	1.88e-05	3.97e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—NRAS—rectum cancer	1.84e-05	3.88e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—NRAS—rectum cancer	1.83e-05	3.85e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—KRAS—rectum cancer	1.82e-05	3.85e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—NRAS—rectum cancer	1.81e-05	3.83e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—KRAS—rectum cancer	1.8e-05	3.8e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—NRAS—rectum cancer	1.8e-05	3.8e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—NRAS—rectum cancer	1.8e-05	3.79e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—KRAS—rectum cancer	1.8e-05	3.79e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—NRAS—rectum cancer	1.8e-05	3.79e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—KRAS—rectum cancer	1.78e-05	3.76e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—KRAS—rectum cancer	1.77e-05	3.73e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—KRAS—rectum cancer	1.77e-05	3.73e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—NRAS—rectum cancer	1.76e-05	3.71e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—NRAS—rectum cancer	1.76e-05	3.71e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—NRAS—rectum cancer	1.76e-05	3.71e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—NRAS—rectum cancer	1.75e-05	3.7e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—TYMS—rectum cancer	1.74e-05	3.68e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—NRAS—rectum cancer	1.71e-05	3.62e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—rectum cancer	1.7e-05	3.59e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—HRAS—rectum cancer	1.7e-05	3.58e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—KRAS—rectum cancer	1.69e-05	3.57e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—NRAS—rectum cancer	1.69e-05	3.57e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—KRAS—rectum cancer	1.68e-05	3.56e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—HRAS—rectum cancer	1.68e-05	3.55e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—NRAS—rectum cancer	1.68e-05	3.55e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—KRAS—rectum cancer	1.68e-05	3.54e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—KRAS—rectum cancer	1.67e-05	3.54e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—KRAS—rectum cancer	1.66e-05	3.51e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—NRAS—rectum cancer	1.66e-05	3.5e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—KRAS—rectum cancer	1.63e-05	3.45e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—KRAS—rectum cancer	1.63e-05	3.44e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—HRAS—rectum cancer	1.63e-05	3.44e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—NRAS—rectum cancer	1.62e-05	3.42e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—NRAS—rectum cancer	1.61e-05	3.39e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HRAS—rectum cancer	1.6e-05	3.37e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—rectum cancer	1.6e-05	3.37e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—KRAS—rectum cancer	1.58e-05	3.34e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—rectum cancer	1.58e-05	3.34e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—KRAS—rectum cancer	1.57e-05	3.32e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—KRAS—rectum cancer	1.56e-05	3.3e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—NRAS—rectum cancer	1.56e-05	3.29e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—NRAS—rectum cancer	1.55e-05	3.28e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HRAS—rectum cancer	1.55e-05	3.27e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—KRAS—rectum cancer	1.55e-05	3.27e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—KRAS—rectum cancer	1.55e-05	3.26e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—KRAS—rectum cancer	1.55e-05	3.26e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HRAS—rectum cancer	1.53e-05	3.23e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—HRAS—rectum cancer	1.53e-05	3.22e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—KRAS—rectum cancer	1.51e-05	3.2e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—KRAS—rectum cancer	1.51e-05	3.2e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—HRAS—rectum cancer	1.51e-05	3.19e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—KRAS—rectum cancer	1.51e-05	3.19e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—KRAS—rectum cancer	1.51e-05	3.19e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HRAS—rectum cancer	1.5e-05	3.17e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—HRAS—rectum cancer	1.5e-05	3.17e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—NRAS—rectum cancer	1.49e-05	3.14e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—NRAS—rectum cancer	1.48e-05	3.13e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—KRAS—rectum cancer	1.47e-05	3.11e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—KRAS—rectum cancer	1.45e-05	3.07e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—rectum cancer	1.45e-05	3.06e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—KRAS—rectum cancer	1.45e-05	3.05e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—HRAS—rectum cancer	1.44e-05	3.04e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—HRAS—rectum cancer	1.43e-05	3.02e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—KRAS—rectum cancer	1.43e-05	3.01e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HRAS—rectum cancer	1.43e-05	3.01e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HRAS—rectum cancer	1.42e-05	3.01e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—HRAS—rectum cancer	1.41e-05	2.98e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—NRAS—rectum cancer	1.41e-05	2.98e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—rectum cancer	1.4e-05	2.95e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—KRAS—rectum cancer	1.39e-05	2.94e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—HRAS—rectum cancer	1.39e-05	2.93e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—rectum cancer	1.39e-05	2.93e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—HRAS—rectum cancer	1.39e-05	2.93e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—KRAS—rectum cancer	1.38e-05	2.92e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—NRAS—rectum cancer	1.37e-05	2.89e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—NRAS—rectum cancer	1.35e-05	2.86e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—HRAS—rectum cancer	1.35e-05	2.84e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—rectum cancer	1.35e-05	2.84e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—rectum cancer	1.35e-05	2.84e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—KRAS—rectum cancer	1.34e-05	2.83e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—HRAS—rectum cancer	1.34e-05	2.82e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—KRAS—rectum cancer	1.34e-05	2.82e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—NRAS—rectum cancer	1.33e-05	2.81e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—NRAS—rectum cancer	1.33e-05	2.81e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—HRAS—rectum cancer	1.33e-05	2.8e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—HRAS—rectum cancer	1.32e-05	2.78e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—HRAS—rectum cancer	1.31e-05	2.77e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HRAS—rectum cancer	1.31e-05	2.77e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TYMS—rectum cancer	1.31e-05	2.77e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—rectum cancer	1.31e-05	2.77e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—HRAS—rectum cancer	1.29e-05	2.72e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—HRAS—rectum cancer	1.29e-05	2.72e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—HRAS—rectum cancer	1.29e-05	2.71e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HRAS—rectum cancer	1.28e-05	2.71e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—KRAS—rectum cancer	1.28e-05	2.7e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—KRAS—rectum cancer	1.28e-05	2.69e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NRAS—rectum cancer	1.26e-05	2.66e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NRAS—rectum cancer	1.26e-05	2.66e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HRAS—rectum cancer	1.25e-05	2.65e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—HRAS—rectum cancer	1.24e-05	2.61e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HRAS—rectum cancer	1.23e-05	2.6e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—KRAS—rectum cancer	1.21e-05	2.56e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—HRAS—rectum cancer	1.21e-05	2.56e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—HRAS—rectum cancer	1.18e-05	2.5e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—KRAS—rectum cancer	1.18e-05	2.49e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HRAS—rectum cancer	1.17e-05	2.48e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—KRAS—rectum cancer	1.16e-05	2.46e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NRAS—rectum cancer	1.16e-05	2.45e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—KRAS—rectum cancer	1.14e-05	2.41e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—KRAS—rectum cancer	1.14e-05	2.41e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—HRAS—rectum cancer	1.14e-05	2.41e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—rectum cancer	1.14e-05	2.4e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—HRAS—rectum cancer	1.13e-05	2.4e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NRAS—rectum cancer	1.13e-05	2.39e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NRAS—rectum cancer	1.09e-05	2.31e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HRAS—rectum cancer	1.09e-05	2.3e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NRAS—rectum cancer	1.09e-05	2.29e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—KRAS—rectum cancer	1.09e-05	2.29e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—HRAS—rectum cancer	1.08e-05	2.29e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—KRAS—rectum cancer	1.08e-05	2.29e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—rectum cancer	1.08e-05	2.28e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—rectum cancer	1.05e-05	2.21e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NRAS—rectum cancer	1.04e-05	2.19e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—rectum cancer	1.03e-05	2.19e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HRAS—rectum cancer	1.03e-05	2.18e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—rectum cancer	1.02e-05	2.15e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—rectum cancer	1.02e-05	2.15e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HRAS—rectum cancer	1e-05	2.12e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KRAS—rectum cancer	9.99e-06	2.11e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HRAS—rectum cancer	9.9e-06	2.09e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KRAS—rectum cancer	9.75e-06	2.06e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HRAS—rectum cancer	9.72e-06	2.05e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HRAS—rectum cancer	9.72e-06	2.05e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—rectum cancer	9.65e-06	2.04e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—rectum cancer	9.62e-06	2.03e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KRAS—rectum cancer	9.4e-06	1.98e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KRAS—rectum cancer	9.35e-06	1.97e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HRAS—rectum cancer	9.22e-06	1.95e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HRAS—rectum cancer	9.2e-06	1.94e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KRAS—rectum cancer	8.94e-06	1.89e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—rectum cancer	8.88e-06	1.88e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—rectum cancer	8.67e-06	1.83e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HRAS—rectum cancer	8.49e-06	1.79e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—rectum cancer	8.35e-06	1.76e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—rectum cancer	8.31e-06	1.75e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HRAS—rectum cancer	8.29e-06	1.75e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TYMS—rectum cancer	8.09e-06	1.71e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HRAS—rectum cancer	7.99e-06	1.69e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HRAS—rectum cancer	7.95e-06	1.68e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—rectum cancer	7.94e-06	1.68e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HRAS—rectum cancer	7.59e-06	1.6e-05	CbGpPWpGaD
